CTRI/2024/07/071196尚未招募4 期
Comparison of Effectiveness and Safety of Dapagliflozin and Empagliflozin in Type 2 Diabetes Mellitus - NI
Dr Manu Arya0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All Patients with Type2 diabetes mellitus as per ADA guidelines
- •Patients of either gender with age more than 18 years.
- •Patients giving written informed consent.
排除标准
- •Pregnant & lactating women.
- •Patients not complying with the study protocol.
- •Patients with underlying comorbid conditions like recurrent UTI, chronic renal diseases.
- •Patients with co-morbid conditions like malignancy, psychiatric disorders, substance abuse
- •Patients with concomitant medications likely to interfere with glycemic control e.g.: Steroids, Beta-blockers, Thiazide Diuretics
研究者
相似试验
已完成
4 期
Comparing Dapagliflozin and Glimepiride in treating patients with type 2 Diabetes.Type 2 DiabetesIRCT20220408054450N1Bahria University Medical & Dental College200
已完成
不适用
Evaluation of efficiency and safety of dapagliflozin in treating of type 2 diabetes mellitustype 2 diabetesJPRN-UMIN000023681Juntendo University Urayasu Hospital30
进行中（未招募）
不适用
Comparison of efficacy and safety of different regimens of sublingual immunotherapy for Ragweed.EUCTR2011-001682-41-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)45
招募中
不适用
Comparison of the the Efficacy and Safety of durable polymer Novolimus-eluting Elixir DESyne X2™ Stent with Bioresorbable Polymer Sirolimus-Eluting Orsiro™ Stent in a Real World” patient populatioKCT0005690Koera University Guro Hospital1,176
已完成
4 期
Comparison of efficacy and safety of Drotaverine Versus Mebeverine in Irritable Bowel SyndromeCTRI/2017/11/010529Walter Bushnell Pvt Ltd200